No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Devices
TaiDoc Technology Corporation, established in 1998 and based in New Taipei City, Taiwan, is a leading global producer and distributor of a wide array of medical devices. The company's comprehensive product catalog features advanced in vitro diagnostics, including multi-parameter monitoring systems, convenient point-of-care testing (POCT) devices, and precision lancet and lancing tools. For animal health, TaiDoc offers specialized veterinary diagnostics such as blood glucose, calcium, and ketone meters. Beyond diagnostics, their general medical equipment range encompasses vital devices like nebulizers, thermometers, blood pressure monitors, vital sign monitors, and pulse oximeters. In the connected health sector, they develop remote telehealth monitoring devices alongside user-friendly smartphone applications. The company also contributes to infectious disease screening, providing rapid antigen test kits for conditions like COVID-19. In addition to its product offerings, TaiDoc delivers value-added services, assisting clients with regulatory professional guidance, clinical consultation, engineering support, and sophisticated manufacturing system solutions. Furthermore, they offer a suite of proprietary software applications designed to enhance device functionality and user experience, such as MyLink, ProCheck, Healthy Check, Healthy Check PRO, PCLink, and a USB adapter driver.
www.taidoc.comNo one on the platform currently holds 4736.TW.
No tracked institution reports a position in 4736.TW as of their last filing.
No one on the platform has traded 4736.TW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 3 of the last 6 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-12 | $3.78 | $12.40 | +228.0% |
| 2026-05-07 | $3.43 | $2.99 | -12.8% |
| 2025-08-06 | $2.25 | $4.90 | +117.8% |
| 2025-05-07 | $2.61 | $-0.16 | -106.1% |
| 2025-03-12 | $2.61 | $4.01 | +53.6% |
| 2024-11-06 | $2.67 | $1.03 | -61.4% |
| $111.00 |
| +0.00% |
| $7.7B |
| — |
| 4129.TWOUnited Orthopedic Corporation | $82.50 | -0.12% | $8.0B | — |
| 4162.TWOPharmaEngine, Inc. | $54.70 | -0.18% | $7.9B | — |
Source: Financial Modeling Prep · peers by sector/industry